drugset
drugset / Trial / NCT04113382

Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy

NCT04113382 ↗

Phase 1/2 Recruiting 30 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupSingle-blindScreening

Summary

Bowel preparation for pediatric colonoscopy.

Timeline

Start
2022-06-23
Primary completion
2027-06
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject CLENPIQ Unknown 80 ml Oral
Comparator POLYETHYLENE GLYCOL 3350 Small molecule 3.4 g/kg Oral
Comparator POLYETHYLENE GLYCOL 3350 Small molecule 4.9 g/kg Oral

Indications

No indication recorded.